Studies related to Infantile Colic and Lactobacillus reuteri

Lactobacillus Reuteri DSM 17938 For The Management Of Infantile Colic In Breastfed Infants: A Randomized, Double-blind, Placebo-controlled Trial

Effect Decrease
Trial Design Double blind
Trial Length 2-4 Weeks
Number of Subjects 80
Gender Both Genders
Age Range 0-1
Notes for this study:
A once daily dose of 10^8^ CFU _l. reuteri_ DSM 17938 to colic infants for four weeks times significantly reduced crying within one week (six infants reporting more than a halving in crying with none in placebo) and after one month all infants reporting more than a halving of crying (60% in placebo).

Full details on all 7 studies are available to Examine Plus members.